Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.


PURPOSE Most patients with breast cancer age ≥ 65 years (ie, older patients) are eligible for adjuvant hormonal therapy, but use is not universal. We examined the influence of frailty on hormonal therapy noninitiation and discontinuation. PATIENTS AND METHODS A prospective cohort of 1,288 older women diagnosed with invasive, nonmetastatic breast cancer… (More)
DOI: 10.1200/JCO.2013.51.7367


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics